BUPRENORPHINE- buprenorphine solution
PAYLESS COMPOUNDERS, LLC

----------

buprenorphine oral solution 30mL

BUPRENORPHINE
buprenorphine solution

Product Information
Product Type	ANIMAL COMPOUNDED DRUG	Item Code (Source)	NDC:70022-010
Route of Administration	ORAL, TRANSMUCOSAL	DEA Schedule	CIII
Reporting Period	20151002-20160402

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BUPRENORPHINE HYDROCHLORIDE (UNII: 56W8MW3EN1) (BUPRENORPHINE - UNII:40D3SCR4GZ)	BUPRENORPHINE	0.3 mg in 1 mL

Ingredient Name	Strength
Inactive Ingredients
METHYLPARABEN (UNII: A2I8C7HI9T)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
WATER (UNII: 059QF0KO0R)
SUCROSE (UNII: C151H8M554)
SODIUM BENZOATE (UNII: OJ245FE5EU)
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
SODIUM CITRATE (UNII: 1Q73Q2JULR)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:70022-010-03	30 mL in 1 BOTTLE, PLASTIC; Number of Units = 30

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		10/02/2015

Labeler - PAYLESS COMPOUNDERS, LLC (031728341)

Name	Address	ID/FEI	Business Operations
Establishment
PAYLESS COMPOUNDERS, LLC		604160239	outsourcing animal drug compounding

Revised: 10/2015

Document Id: b2956396-7f93-4fee-8988-512791173abb

Set id: 8081ccb8-1b38-4673-a9dd-0fb18fa6038a

Version: 1

Effective Time: 20151002

PAYLESS COMPOUNDERS, LLC